A live-attenuated SARS-CoV-2 vaccine candidate with accessory protein deletions

Yang Liu; Xianwen Zhang; Jianying Liu; Hongjie Xia; Jing Zou; Antonio E. Muruato; Sivakumar Periasamy; Jessica A. Plante; Nathen E. Bopp; Chaitanya Kurhade; Alexander Bukreyev; Ping Ren; Tian Wang; Vineet D. Menachery; Kenneth S. Plante; Xuping Xie; Scott C. Weaver; Pei-Yong Shi.
Preprint en Inglés | PREPRINT-BIORXIV | ID: ppbiorxiv-480460

Documentos relacionados

  1. A live-attenuated SARS-CoV-2 vaccine candidate with accessory protein deletions.
  2. A live-attenuated SARS-CoV-2 vaccine candidate with accessory protein deletions.
  3. A trans-complementation system for SARS-CoV-2 recapitulates authentic viral replication without virulence.
  4. Intranasal respiratory syncytial virus vaccine attenuated by codon-pair deoptimization of seven open reading frames is genetically stable and elicits mucosal and systemic immunity and protection against challenge virus replication in hamsters.
  5. Human parainfluenza virus 3 vaccine candidates attenuated by codon-pair deoptimization are immunogenic and protective in hamsters.
  6. Contribution of SARS-CoV-2 Accessory Proteins to Viral Pathogenicity in K18 Human ACE2 Transgenic Mice.
  7. A SCID Mouse Model To Evaluate the Efficacy of Antivirals against SARS-CoV-2 Infection.
  8. Stable Cell Clones Harboring Self-Replicating SARS-CoV-2 RNAs for Drug Screen.
  9. SARS-CoV-2 Uses Nonstructural Protein 16 To Evade Restriction by IFIT1 and IFIT3.
  10. Virological characteristics of the SARS-CoV-2 Omicron BA.2 spike.